Home › Funds › Ikarian Capital, LLC › CCCC

Ikarian Capital, LLC position in CCCC

C4 THERAPEUTICS INC · Health Care

Ikarian Capital, LLC reported holding 2,433,000 shares of CCCC (C4 THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$11.4M, representing 1.82% of its reported portfolio and ranking #12 among its reported holdings. Ikarian Capital, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)2.43M sh
Reported value held$11.36M
Portfolio Weight1.82%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's CCCC position evolved

Ikarian Capital, LLC first disclosed a stake in CCCC in Q2 2026 at 2,433,000 shares (US$11.4M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.43M $11.36M New

About CCCC and 13F data

CCCC (C4 THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in CCCC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$37.4M), Lynx1 Capital Management LP (US$34.2M), Bain Capital Life Sciences Investors, LLC (US$33.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CCCC

All CCCC fund holders →

FAQ

How long has Ikarian Capital, LLC held CCCC?

Ikarian Capital, LLC has disclosed CCCC holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Ikarian Capital, LLC's current position in CCCC?

As of Q2 2026, Ikarian Capital, LLC holds 2.43M shares of CCCC (C4 THERAPEUTICS INC), valued at $11.36M, representing 1.82% of its reported portfolio and ranking #12.

Has Ikarian Capital, LLC been buying or selling CCCC?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC newly opened its position in CCCC.

Which other funds hold CCCC?

Other major institutional holders of CCCC include RA CAPITAL MANAGEMENT, L.P., Lynx1 Capital Management LP, Bain Capital Life Sciences Investors, LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.